Skip to main content

April 2013

 

 

academics

 

Clinical research courses

Walk in interview from Senior Research Fellow in CPCRI

The Coconut Research Station at Kasaragod in Kerala was initially established in 1916 by the then Government of Madras and subsequently it was taken over by the Indian Central Coconut Committee in 1948. Central Plantation Crops Research Institute (CPCRI) was established in 1970 as one of the agricultural research institutes in the National Agricultural Research System (NARS) under the Indian Council of Agricultural Research (ICAR).

ANTIOXIDANT AND THEIR THERAPEUTIC ROLE IN HUMAN HEALTH CARE

ABOUT AUTHORS:
Mrs.R.Deepa
Assistant professor, Department of biochemistry
Madha dental college and hospital, kundrathur
Chennai, Tamil Nadu.
deepanish1981@gmail.com

AN UPDATED PHARMACEUTICAL CRUDE DRUG PROFILE

Pharmacognostical Crude drug Profile:

Application are invited from Pharmacist/B in NPCIL

Nuclear Power Corporation of India Limited is a Public Sector Enterprise under the administrative control of the Department of Atomic Energy (DAE), Government of India.

Walk in interview from Research Associate Bose Institute

The institute has evolved over the years into a multi-disciplinary research organization with stress on fundamental research in its pursuit of advancement of knowledge in Science and technology and at the same time developing highly competent and able scientific manpower for the country.

CHRONOPHARMACOLOGY: AN OVERVIEW

ABOUT AUTHORS:
Pankaj Sharma*, Bhupendra Vyas, Yuvraj Singh Sarangdevot, Abhishek Sharma, Bhuvanesh Sharma
Department of Quality Assurance,
Bhupal Nobles’ College of Pharmacy,
Udaipur- 313002, Rajasthan, India
*pankajs.medicolite@gmail.com

BUTEA MONOSPERMA A TRADITIONAL MEDICINAL PLANT: - AN OVERVIEW

About Authors:
Sunil Roshan1, Prabhakar Sharma*1, Ramchandra Gupta1, Sudhakar Sharma2
1Department of Pharmacognosy, GRKIST (Pharmacy)
2Takshashila Institute Of Science And Technology
Jabalpur, M.P.
*prabhakar.sharma071026@gmail.com

Abstract
The traditional systems of medicine together with homoeopathy and folklore medicine continue to play a significant role largely in the health care system of the population. Butea monosperma(palas) belonging to the family leguminosae grown wildly in many parts of India. The plant is highly uses by the rural and tribal people in curing various disorders. Flowers are used as drug in many ailments like eye disease, chronic fever, enlargement of spleen, leucorrhoea, epilepsy, leprosy, antifungal activity, anti-inflammatory activity, liver disorders antifertility activity and gout etc. The plant parts are used in the form of extract, juice, infusion, powder and gum. The present paper enumerates various pharmacognostic and pharmacological aspects of the plant. This review also summaries the therapeutic potential of this plant.This is a moderate sized deciduous tree which is widely distributed throughout India, Burma and Ceylon, popularly known as 'dhak' or 'palas', commonly known as ‘flame of forest’. In this review an attempt has been done to highlight the work on Butea monosperma having pharmacological potential.

Opening for Medical Coding Executive in GeBBS Healthcare

GeBBS is a leading provider of healthcare Business Process Outsourcing services to Healthcare Providers (Medical Billing companies, Hospitals, Faculty Practices, ASC’s, LTC’s, etc.) and Pharmacies. We help our clients succeed by leveraging on our domain expertise and technology platforms along with our cost effective approach to global outsourcing.

Central Drug Research Institute invites M.Pharm, M.Sc ( 22 posts) for Research Associate, Project Fellow, Senior Research Fellow

CSIR-Central Drug Research Institute, Lucknow is a premier R&D Institute under the aegis of the Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India.

Career as Manager / Sr.Manager - IP in Mylan

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.